Parametric Portfolio Associates’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $7.51M | Sell |
|
|||||
|
2021
Q4 | $10.7M | Sell |
|
|||||
|
2021
Q3 | $10M | Buy |
|
|||||
|
2021
Q2 | $7.02M | Sell |
|
|||||
|
2021
Q1 | $8.69M | Sell |
|
|||||
|
2020
Q4 | $14.9M | Sell |
|
|||||
|
2020
Q3 | $15.7M | Sell |
|
|||||
|
2020
Q2 | $19.2M | Sell |
|
|||||
|
2020
Q1 | $13.7M | Sell |
|
|||||
|
2019
Q4 | $19.8M | Buy |
|
|||||
|
2019
Q3 | $15.3M | Sell |
|
|||||
|
2019
Q2 | $21.3M | Sell |
|
|||||
|
2019
Q1 | $23.5M | Buy |
|
|||||
|
2018
Q4 | $19M | Sell |
|
|||||
|
2018
Q3 | $48.2M | Sell |
|
|||||
|
2018
Q2 | $41.1M | Sell |
|
|||||
|
2018
Q1 | $34.9M | Buy |
|
|||||
|
2017
Q4 | $25.5M | Sell |
|
|||||
|
2017
Q3 | $27.5M | Buy |
|
|||||
|
2017
Q2 | $22.8M | Buy |
|
|||||
|
2017
Q1 | $17.4M | Sell |
|
|||||
|
2016
Q4 | $19.3M | Buy |
|
|||||
|
2016
Q3 | $18.2M | Buy |
|
|||||
|
2016
Q2 | $19.1M | Sell |
|
|||||
|
2016
Q1 | $20.8M | Buy |
|
|||||
|
2015
Q4 | $3.46M | Buy |
|
|||||
|
2015
Q3 | $1.74M | Buy |
|
|||||
|
2015
Q2 | $2.03M | Buy |
|
|||||
|
2015
Q1 | $1.31M | Buy |
|
|||||
|
2014
Q4 | $497K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $351K | Sell |
|
|||||
|
2014
Q1 | $453K | Buy |
|
|||||
|
2013
Q4 | $244K | Sell |
|
|||||
|
2013
Q3 | $333K | Sell |
|
|||||
|
2013
Q2 | $702K | Buy |
|